Revolutionizing Kidney Disease Management: Proton Intelligence Secures $6.95M in Seed Funding for Innovative Potassium Monitoring Wearable

Proton Intelligence is proud to announce that we have successfully raised $6.95 million in our latest funding round, a significant step forward in our mission to revolutionize patient care for those living with kidney disease. Our cutting-edge technology aims to tackle one of the most pressing challenges in nephrology: the need for real-time, continuous potassium monitoring. Our wearable device enables clinicians to monitor a patient's potassium levels instantaneously, providing a crucial data stream that has the potential to transform treatment protocols. With this new funding, our primary objective is to accelerate the development and deployment of our potassium monitoring system, which is poised to unlock life-saving treatments that are currently hindered by unsafe potassium levels. By providing clinicians with precise and timely insights into a patient's condition, we aim to facilitate safer prescribing practices and ultimately enhance patient outcomes. This significant investment not only underscores the confidence our investors have in our vision but also reinforces our commitment to advancing healthcare technology. As we move forward, we are dedicated to ensuring that our innovative solutions reach the patients and healthcare providers who need them most, paving the way for a future where kidney disease management is both proactive and effective. Together, we are confident that Proton Intelligence will set a new standard in patient care, making a lasting impact on the lives of kidney disease patients and their families.